Science & Enterprise logo
Science for business people. Enterprise for scientists.
  • Cloud Computing Harnessed for Cancer Data Analysis

    Researchers at Johns Hopkins University in Baltimore will collect large volumes of cancer data, down to the level of individual cells, using cloud computing to amass and analyze the data. The team of engineering and medical researchers is led by Denis Wirtz, associate director of Johns Hopkins’s Institute for NanoBio Technology, and funded by a…

  • Trial to Test Electronic Media for Brain Injury Care

    The Mayo Clinic in Rochester, Minnesota and collaborators in the upper Midwest will examine ways to use electronic media to improve the care of patients with traumatic brain injury (TBI) in rural and underserved urban areas. The five-year clinical study is funded by a $2.2 million grant from the National Institute on Disability and Rehabilitation…

  • Stronger, Tougher Steel Variety Developed

    Engineers at Wayne State University in Detroit developed a new type of steel that they say is stronger and more resistant to fracture, and can also resist the fatigue encountered with similar materials. The work of engineering professor Susil Putatunda, leading this research group, is supported by National Science Foundation, Michigan Initiative for Innovation and…

  • University Project Aims to Cut Nursing Home Hospitalizations

    A new project at University of Missouri school of nursing aims to cut avoidable hospitalizations among nursing home residents. The study, led by nursing professor Marilyn Rantz is funded by a four-year $15 million grant from the Centers for Medicare and Medicaid Services (CMS), an agency of the U.S. Department of Health and Human Services.…

  • Heartbeat Vibrations Found Feasible to Power Pacemakers

    Engineers at University of Michigan in Ann Arbor developed a device that can harvest enough energy from a beating heart to power an implanted pacemaker. Michigan engineering research fellow Amin Karami (pictured right) and colleague Daniel Inman presented their findings yesterday at a meeting of the American Heart Association in Los Angeles. Pacemakers help regulate…

  • European Commission Approves Metabolic Disorder Gene Therapy

    The biotechnology company uniQure BV in Amsterdam says the European Commission approved Glybera, its gene therapy for patients with lipoprotein lipase deficiency, a rare metabolic disorder. The approval of Glybera, says uniQure, represents the first gene therapy approved by the European Commission. Lipoprotein lipase deficiency, also called familial hyperchylomicronemia, is an inherited condition that disrupts…

  • Pilot Clinical Trial Indicates Glaucoma Drug Efficacy

    Results from a pilot clinical trial suggests a drug made by Aerie Pharmaceuticals of Bedminister, New Jersey is effective at treating glaucoma. The phase 2a trial tested Aerie’s candidate AR-13324 with 80 patients at 11 locations in the U.S. between March and July 2012. The patients enrolled in the double-blinded trial had open angle glaucoma,…

  • Vertex to Partner with Janssen, GSK on Hepatitis C Drugs

    Vertex Pharmaceuticals Inc. in Cambridge, Massachusetts will collaborate with Janssen Pharmaceuticals, a division of Johnson & Johnson, and GlaxoSmithKline (GSK) on clinical trials of Vertex’s VX-135 treatment candidate for hepatitis C. The trials will test VX-135 in combination with hepatitis C drugs made by Janssen and GSK. Financial details of the agreements were not disclosed.…

  • Wake Forest, NanoMedica to Partner on Sequencing Technology

    Physicists at Wake Forest University in Winston-Salem, North Carolina and NanoMedica Inc., a biotechnology company also in Winston-Salem, received a Small Business Innovation Research grant to develop a faster process of drug development. The $700,000 grant from National Institutes of Health is supplemented by a $160,000 award from North Carolina Biotech Center to develop the…

  • Pfizer Develops Equine Vaccine from University Research

    The Australian division of Pfizer Animal Health in Brisbane released today a new vaccine to prevent disease from the Hendra virus that can be fatal to horses and humans. Pfizer’s Equivac HeV is the product of research conducted at Uniformed Services University of the Health Sciences (USU) and licensed from the Henry M. Jackson Foundation…